Editorial: risky business. What do sufferers' perceptions of risk from interventions for irritable bowel syndrome really mean?

Aliment Pharmacol Ther. 2022 May;55(9):1218-1219. doi: 10.1111/apt.16909.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Attitude to Health
  • Humans
  • Irritable Bowel Syndrome*
  • Surveys and Questionnaires